Jonas A. Nilsson - Concepedia

Author

Jonas A. Nilsson

Also Known As

J A Nilsson, J Nilsson, J. Nilsson, J.A. Nilsson, JONAS A. NILSSON, Joakim Karlsson, Jonas A Nilsson, Jonas A. Nilsson, Jonas Andreas Nilsson, Jonas NILSSON

274

Publications

11.1K

Citations

H-Index

123

Concepts

All Affiliations

University of Gothenburg Sahlgrenska University Hospital Umeå University St. Jude Children's Research Hospital Technical University of Munich

About

Jonas A. Nilsson is an author at University of Gothenburg specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	40	5.6K
2	Natural Sciences	6	6	549
3	Engineering	3	3	1K
4	Health Sciences	3	3	506
5	Public Health	3	3	97

Jonas A. Nilsson

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors Su Chul Jang, Oh Youn Kim, Chang Min Yoon, ACS Nano NanoparticlesNanotherapeuticsEngineeringTargeted DeliveryBiomedical Engineering	2013	987
Antioxidants Accelerate Lung Cancer Progression in Mice Volkan I. Sayin, Mohamed X. Ibrahim, Erik Larsson, Science Translational Medicine	2014	832
DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity Anetta Härtlová, Saskia F. Erttmann, Faizal A.M. Raffi, Immunity Host ResponseDna DamageAnti-microbial Innate ImmunityPathogenesisImmunology	2015	695
Antioxidants can increase melanoma metastasis in mice Kristell Le Gal, Mohamed X. Ibrahim, Clotilde Wiel, Science Translational Medicine	2015	612
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression Troy A. Baudino, Catriona McKay, Hélène Pendeville-Samain, Genes & Development	2002	530
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool Helge Gad, Tobias Koolmeister, Ann‐Sofie Jemth, Nature Tumor BiologyDntp PoolMth1 InhibitionOncologyMedicine	2014	525
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants Michael T. Hemann, Anka Bric, Julie Teruya‐Feldstein, Nature Tumor HeterogeneityMedicineTumour-derived Myc MutantsTumor SuppressorRadiation Oncology	2005	449
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types Nils Johan Fredriksson, Lars Ny, Jonas A. Nilsson, Nature Genetics Somatic VariantSomatic MutationsTumor HeterogeneityGeneticsSystematic Analysis	2014	302
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state Jürgen den Hollander, Sara Rimpi, Joanne R. Doherty, Blood	2010	247
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis Michiel Smits, Jonas A. Nilsson, Shahryar E. Mir, Oncotarget	2010	232

Page 1